Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Machinify is a leading healthcare intelligence company formed through the strategic merger of several industry leaders, including The Rawlings Group, Apixio's Payment Integrity business, and Varis, under the stewardship of New Mountain Capital. The company provides an AI-powered software platform designed to transform healthcare administration by automating and optimizing the claims lifecycle, payment accuracy, and audit processes. By leveraging advanced machine learning and a vast repository of clinical and claims data, Machinify helps national and regional health plans identify billing errors, prevent overpayments, and reduce administrative waste. Following its 2025 acquisition of Performant Healthcare, the company significantly expanded its footprint into government-sponsored programs, establishing itself as a dominant force in the multi-billion dollar payment integrity market. Machinify currently serves over 75 health plans, including a majority of the top 20 U.S. payers, impacting the administration of benefits for more than 170 million lives.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Unnamed entity.